Improving differential diagnosis of pulmonary large cell neuroendocrine carcinoma and small cell lung cancer via a transcriptomic, biological pathway-based machine learning model
Background: Accurately differentiating between pulmonary large cell neuroendocrine carcinomas (LCNEC) and small cell lung cancer (SCLC) is crucial to make appropriate therapeutic decisions. Here, a classifier was constructed based on transcriptome data to improve the diagnostic accuracy for LCNEC an...
Main Authors: | Junhong Guo, Likun Hou, Wei Zhang, Zhengwei Dong, Lei Zhang, Chunyan Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S193652332100214X |
Similar Items
-
Diagnosis and Molecular Profiles of Large Cell Neuroendocrine Carcinoma With Potential Targets for Therapy
by: Helmut Popper, et al.
Published: (2021-07-01) -
Neuroendocrine Tumors of the Lung
by: Melanie Demes, et al.
Published: (2012-07-01) -
Resected thymic large cell neuroendocrine carcinoma: report of a case
by: Hiromitsu Domen, et al.
Published: (2018-11-01) -
A case of colorectal large cell neuroendocrine carcinoma accompanied by disseminated peritoneal leiomyomatosis
by: Kunihiko Suga, et al.
Published: (2020-12-01) -
Long‐term survivor of pulmonary combined large cell neuroendocrine carcinoma treated with nivolumab
by: Risa Oda, et al.
Published: (2020-07-01)